🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Manabu Futamura

Gifu University Hospital

ORCID: 0000-0001-5622-8352

Also affiliated with Gifu University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer”.

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Scientific Reports(2020)10.1038/s41598-020-73624-w
N/A
0.807DataRank · unranked
216 citations

Yoshihisa Tokumaru, Mariko Asaoka, Li Yan, Vikas Satyananda, Ryusei Matsuyama +7 more

Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation

International Journal of Molecular Sciences(2020)10.3390/ijms21165744
N/A
0DataRank · unranked
56 citations

Masanori Oshi, Eriko Katsuta, Li Yan, Jing Huang, Masayuki Nagahashi +5 more

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?

Translational Cancer Research(2020)10.21037/tcr-20-2231
N/A
0DataRank · unranked
2 citations

Lan Le, Mariko Asaoka, Manabu Futamura, Takashi Ishikawa, Kazuhiro Yoshida +2 more

Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer

Scientific Reports(2021)10.1038/s41598-021-93681-z
N/A
0DataRank · unranked
22 citations

Masanori Oshi, Michelle R. Huyser, Li Yan, Masahiro Fukada, Nobuhisa Matsuhashi +5 more

Low expression of microRNA-195 is a poor prognostic marker for ER-positive breast cancer patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12576
N/A
0DataRank · unranked
2 citations

Masanori Oshi, Eriko Katsuta, Vijayashree Murthy, Nobuhisa Matsuhashi, Manabu Futamura +3 more

Can Intratumoral neutrophil lymphocyte ratio (NLR) be a prognostic biomarker in breast cancer patients?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12573
N/A
0DataRank · unranked
2 citations

Masanori Oshi, Vijayashree Murthy, Eriko Katsuta, Nobuhisa Matsuhashi, Manabu Futamura +3 more